세계의 체외수정(IVF) 기기 및 용품 시장 : 제품, 기능, 최종사용자별 예측(2025-2030년)

The In-Vitro Fertilization Devices & Supplies Market was valued at USD 7.42 billion in 2023, expected to reach USD 8.05 billion in 2024, and is projected to grow at a CAGR of 8.59%, to USD 13.22 billion by 2030.

The In-Vitro Fertilization (IVF) Devices & Supplies market encompasses a broad range of instruments and consumables essential for aiding fertility treatments. The scope includes devices like culture media, incubators, cryosystems, microscopes, and sperm separation systems, ensuring seminal processing, egg retrieval, fertilization, and embryo development. The necessity arises from growing infertility rates, delayed parenthood, advancements in reproductive technologies, and supportive governmental policies. Applications extend to fertility clinics, hospitals, and cryobanks, catering to end-users which include both individuals and couples seeking fertility assistance. Market growth is fueled by technological advancements, increased medical tourism for fertility treatments, and rising public awareness about infertility solutions. Prospective opportunities emerge from the integration of artificial intelligence and machine learning in improving IVF outcomes, expansion of fertility care services in developing regions, and innovation in minimally invasive tools enhancing procedural precision. Recommendations to seize these opportunities include investment in R&D for next-generation devices, strategic partnerships with reproductive health specialists, and digital marketing campaigns to increase brand visibility. Challenges such as the high cost of IVF procedures, ethical concerns, and stringent regulatory frameworks hinder market expansion. Furthermore, lack of awareness in certain regions and cultural stigmatization restrict product adoption. Innovative areas include the development of personalized IVF solutions utilizing genomics, improvements in embryo screening processes, and advancements in cryopreservation techniques. The IVF Devices & Supplies market is dynamic and competitive, driven heavily by technological progress and changing societal norms around family planning. Continued research in optimizing infertility treatments and adapting to regulatory changes is essential for sustained market growth. Companies should focus on both emerging markets with growing demand and technology-driven improvements in western markets to capitalize on evolving trends and broaden their impact effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving In-Vitro Fertilization Devices & Supplies Market

The In-Vitro Fertilization Devices & Supplies Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Decline in fertility rate worldwide
  • Government support to promote IVF treatments
  • Increasing availability of IVF treatment centers
• Market Restraints
  • Expensive treatment with low success rate
• Market Opportunities
  • Technological advancements in IVF devices
  • Investment and funding R&D for new IVF treatment
• Market Challenges
  • Ethical concerns among patients in many economies

Porter's Five Forces: A Strategic Tool for Navigating the In-Vitro Fertilization Devices & Supplies Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the In-Vitro Fertilization Devices & Supplies Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the In-Vitro Fertilization Devices & Supplies Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the In-Vitro Fertilization Devices & Supplies Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the In-Vitro Fertilization Devices & Supplies Market

A detailed market share analysis in the In-Vitro Fertilization Devices & Supplies Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the In-Vitro Fertilization Devices & Supplies Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the In-Vitro Fertilization Devices & Supplies Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the In-Vitro Fertilization Devices & Supplies Market

A strategic analysis of the In-Vitro Fertilization Devices & Supplies Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the In-Vitro Fertilization Devices & Supplies Market, highlighting leading vendors and their innovative profiles. These include Cook Medical Inc., CooperSurgical Inc., EMD Serono Inc. by Merck KGaA, Esco Micro Pte. Ltd., Gynotec B.V., Hamilton Thorne, Ltd., IVFtech ApS, KG Medical Industries, Microtech IVF s.r.o., Nidacon International AB, Nikon Corporation, Oxford Gene Technology By Sysmex Corporation, Rocket Medical PLC, Thermo Fisher Scientific Inc., and Vitrolife AB.

Market Segmentation & Coverage

This research report categorizes the In-Vitro Fertilization Devices & Supplies Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Accessories & Disposables, Instruments, and Reagent & Media. The Instruments is further studied across Cabinet, Cryosystem, Imaging System, Incubator, Micromanipulator System, Ovum Aspiration Pump, and Sperm Separation System. The Reagent & Media is further studied across Cryopreservation Media, Embryo culture Media, Ovum processing Media, and Semen processing Media.
• Based on Function, market is studied across Frozen Embryo Replacement, Intracytoplasmic Sperm Injection, and Pre-Implantation Genetic Diagnosis.
• Based on End User, market is studied across Contract Research Organizations, Cryobank, Fertility Clinics, Hospitals & Care Providers, and Surgical Centers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Decline in fertility rate worldwide
    • 5.1.1.2. Government support to promote IVF treatments
    • 5.1.1.3. Increasing availability of IVF treatment centers
  • 5.1.2. Restraints
    • 5.1.2.1. Expensive treatment with low success rate
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in IVF devices
    • 5.1.3.2. Investment and funding R&D for new IVF treatment
  • 5.1.4. Challenges
    • 5.1.4.1. Ethical concerns among patients in many economies
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. In-Vitro Fertilization Devices & Supplies Market, by Product

• 6.1. Introduction
• 6.2. Accessories & Disposables
• 6.3. Instruments
  • 6.3.1. Cabinet
  • 6.3.2. Cryosystem
  • 6.3.3. Imaging System
  • 6.3.4. Incubator
  • 6.3.5. Micromanipulator System
  • 6.3.6. Ovum Aspiration Pump
  • 6.3.7. Sperm Separation System
• 6.4. Reagent & Media
  • 6.4.1. Cryopreservation Media
  • 6.4.2. Embryo culture Media
  • 6.4.3. Ovum processing Media
  • 6.4.4. Semen processing Media

7. In-Vitro Fertilization Devices & Supplies Market, by Function

• 7.1. Introduction
• 7.2. Frozen Embryo Replacement
• 7.3. Intracytoplasmic Sperm Injection
• 7.4. Pre-Implantation Genetic Diagnosis

8. In-Vitro Fertilization Devices & Supplies Market, by End User

• 8.1. Introduction
• 8.2. Contract Research Organizations
• 8.3. Cryobank
• 8.4. Fertility Clinics
• 8.5. Hospitals & Care Providers
• 8.6. Surgical Centers

9. Americas In-Vitro Fertilization Devices & Supplies Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific In-Vitro Fertilization Devices & Supplies Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa In-Vitro Fertilization Devices & Supplies Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Cook Medical Inc.
• 2. CooperSurgical Inc.
• 3. EMD Serono Inc. by Merck KGaA
• 4. Esco Micro Pte. Ltd.
• 5. Gynotec B.V.
• 6. Hamilton Thorne, Ltd.
• 7. IVFtech ApS
• 8. KG Medical Industries
• 9. Microtech IVF s.r.o.
• 10. Nidacon International AB
• 11. Nikon Corporation
• 12. Oxford Gene Technology By Sysmex Corporation
• 13. Rocket Medical PLC
• 14. Thermo Fisher Scientific Inc.
• 15. Vitrolife AB